Skip to content

Clinical trials

Completed Phase 2/3 Bipolar Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 2/3 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20081
20091
20102
20123
20141
20181
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NeuroRx, Inc.2
The University of New South Wales2
University of Sao Paulo2
Astellas Pharma Inc1
Biohaven Therapeutics Ltd.1
Charite University, Berlin, Germany1
Douglas Mental Health University Institute1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
National Cheng-Kung University Hospital1
Tufts Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder15
Major Depressive Disorder2
Affective Disorders, Psychotic1
Depressive Disorder1
Mania1
Psychotic Disorders1
Schizophrenia1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.